Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2025)
Revolution Medicines (RVMD) recorded quarterly Amortizatization of Intangibles of $99000.0 in Q4 2025, down 67.0% quarter-over-quarter from $300000.0 in Q3 2025, and up 105.79% on a YoY basis from $48108.2 in Q4 2024.
Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Revolution Medicines' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $99000.0 for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles rose 105.79% year-over-year to $99000.0; the TTM figure through Mar 2026 stood at $699000.0 (up 182.82% YoY), while the FY2025 annual figure was $900000.0, down 18.18% from the prior year.
- Amortizatization of Intangibles was $99000.0 for Q4 2025 at Revolution Medicines, down from $300000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $21.4 million in Q4 2023 to a low of -$2.4 million in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $990700.0 across 5 years, with a median of $300000.0 in 2021.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 316.0% in 2022, then soared 1005.46% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$1.1 million in 2021, then tumbled by 114.71% to -$2.4 million in 2022, then jumped by 1005.46% to $21.4 million in 2023, then plunged by 107.99% to -$1.7 million in 2024, then soared by 105.79% to $99000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $99000.0 (Q4 2025), $300000.0 (Q3 2025), and $300000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 99,000.00 |
| Dec 31, 2025 | 99,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 267,000.00 |
| Mar 31, 2025 | 267,000.00 |
| Dec 31, 2024 | -1.71 Mn |
| Dec 31, 2024 | -1.71 Mn |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 267,000.00 |
| Mar 31, 2024 | 267,000.00 |
| Dec 31, 2023 | 21.41 Mn |
| Dec 31, 2023 | 21.41 Mn |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |